Embryonic and embryonic-like stem cells in heart muscle engineering

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 2, 2011, Pages 320-326

  Zimmermann, Wolfram Hubertus ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cardiac repair; Cardiomyocytes; Disease model; Embryonic stem cells; Tissue engineering

Indexed keywords

AUTOLOGOUS STEM CELL TRANSPLANTATION; CARCINOGENESIS; DEVELOPMENTAL BIOLOGY; DISEASE MODEL; DRUG SCREENING; DRUG TARGETING; EMBRYO DEVELOPMENT; EMBRYONIC LIKE STEM CELL; EMBRYONIC STEM CELL; GENETIC DISORDER; HEART DEVELOPMENT; HEART MUSCLE; HLA SYSTEM; HUMAN; IN VITRO STUDY; KARYOTYPE; MYOCARDIAL DISEASE; NONHUMAN; PARTHENOGENESIS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SPERMATOGONIUM; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HEART; HUMANS; MYOCARDIUM; REGENERATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE THERAPY;

EID: 79151485087     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.027     Document Type: Review

References (88)

1. Zimmermann W.H. Remuscularizing failing hearts with tissue engineered myocardium. Antioxid Redox Signal 2009, 11:2011-2023.
2. Moscona A. Rotation-mediated histogenetic aggregation of dissociated cells. A quantifiable approach to cell interactions in vitro. Exp Cell Res 1961, 22:455-475.
3. Sperelakis N. Cultured heart cell reaggregate model for studying cardiac toxicology. Environ Health Perspect 1978, 26:243-267.
4. Zimmermann W.H., Eschenhagen T. Cardiac tissue engineering for replacement therapy. Heart Fail Rev 2003, 8:259-269.
5. Kolodney M.S., Elson E.L. Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts. J Biol Chem 1993, 268:23850-23855.
6. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 1997, 11:683-694.
7. Zimmermann W.H., Fink C., Kralisch D., Remmers U., Weil J., Eschenhagen T. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000, 68:106-114.
8. Leor J., Aboulafia-Etzion S., Dar A., Shapiro L., Barbash I.M., Battler A., et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium?. Circulation 2000, 102:III56-III61.
9. Freed L.E., Vunjak-Novakovic G. Microgravity tissue engineering. In Vitro Cell Dev Biol Anim 1997, 33:381-385.
10. Li R.K., Jia Z.Q., Weisel R.D., Mickle D.A., Choi A., Yau T.M. Survival and function of bioengineered cardiac grafts. Circulation 1999, 100:II63-II69.
11. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002, 90:e40.
12. Morritt A.N., Bortolotto S.K., Dilley R.J., Han X., Kompa A.R., McCombe D., et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 2007, 115:353-360.
13. Ott H.C., Matthiesen T.S., Goh S.K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
14. Vunjak-Novakovic G., Tandon N., Godier A., Maidhof R., Marsano A., Martens T.P., et al., Challenges in cardiac tissue engineering. Tissue Eng Part B Rev 2010;16: 169-187.
15. Eschenhagen T., Didie M., Heubach J., Ravens U., Zimmermann W.H. Cardiac tissue engineering. Transpl Immunol 2002, 9:315-321.
16. Zimmermann W.H., Eschenhagen T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc Med 2007, 17:134-140.
17. Shimizu T., Yamato M., Kikuchi A., Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 2003, 24:2309-2316.
18. Marikawa Y., Alarcon V.B. Establishment of trophectoderm and inner cell mass lineages in the mouse embryo. Mol Reprod Dev 2009, 76:1019-1032.
19. Cockburn K., Rossant J. Making the blastocyst: lessons from the mouse. J Clin Nature 2010;465: 995-1003.
20. Tam P.P., Behringer R.R. Mouse gastrulation: the formation of a mammalian body plan. Mech Dev 1997, 68:3-25.
21. Huber T.L., Kouskoff V., Fehling H.J., Palis J., Keller G. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 2004, 432:625-630.
22. Kitajima S., Takagi A., Inoue T., Saga Y. MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development 2000, 127:3215-3226.
23. Cai C.L., Liang X., Shi Y., Chu P.H., Pfaff S.L., Chen J., et al. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003, 5:877-889.
24. Biben C., Harvey R.P. Homeodomain factor Nkx2-5 controls left/right asymmetric expression of bHLH gene eHand during murine heart development. Genes Dev 1997, 11:1357-1369.
25. Riley P., Anson-Cartwright L., Cross J.C. The Hand1 bHLH transcription factor is essential for placentation and cardiac morphogenesis. Nat Genet 1998, 18:271-275.
26. Srivastava D., Thomas T., Lin Q., Kirby M.L., Brown D., Olson E.N. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet 1997, 16:154-160.
27. Molkentin J.D., Lin Q., Duncan S.A., Olson E.N. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 1997, 11:1061-1072.
28. Laugwitz K.L., Moretti A., Lam J., Gruber P., Chen Y., Woodard S., et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005, 433:647-653.
29. Moretti A., Caron L., Nakano A., Lam J.T., Bernshausen A., Chen Y., et al. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006, 127:1151-1165.
30. Domian I.J., Chiravuri M., van der Meer P., Feinberg A.W., Shi X., Shao Y., et al. Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science 2009, 326:426-429.
31. Yang L., Soonpaa M.H., Adler E.D., Roepke T.K., Kattman S.J., Kennedy M., et al. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature 2008, 453:524-528.
32. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
33. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
34. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
35. Maltsev V.A., Rohwedel J., Hescheler J., Wobus A.M. Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 1993, 44:41-50.
36. Klug M.G., Soonpaa M.H., Koh G.Y., Field L.J. Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 1996, 98:216-224.
37. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001, 108:407-414.
38. Caspi O., Lesman A., Basevitch Y., Gepstein A., Arbel G., Habib I.H., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007, 100:263-272.
39. Guo X.M., Zhao Y.S., Chang H.X., Wang C.Y., E LL., Zhang X.A., et al. Creation of engineered cardiac tissue in vitro from mouse embryonic stem cells. Circulation 2006, 113:2229-2237.
40. Kaufman M.H., Robertson E.J., Handyside A.H., Evans M.J. Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol 1983, 73:249-261.
41. Guan K., Nayernia K., Maier L.S., Wagner S., Dressel R., Lee J.H., et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006, 440:1199-1203.
42. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
43. Zhang D., Pan L., Yang L.H., He X.K., Huang X.Y., Sun F.Z. Strontium promotes calcium oscillations in mouse meiotic oocytes and early embryos through InsP3 receptors, and requires activation of phospholipase and the synergistic action of InsP3. Hum Reprod 2005, 20:3053-3061.
44. Cibelli J.B., Cunniff K., Vrana K.E. Embryonic stem cells from parthenotes. Methods Enzymol 2006, 418:117-135.
45. Kim K., Ng K., Rugg-Gunn P.J., Shieh J.H., Kirak O., Jaenisch R., et al. Recombination signatures distinguish embryonic stem cells derived by parthenogenesis and somatic cell nuclear transfer. Cell Stem Cell 2007, 1:346-352.
46. Revazova E.S., Turovets N.A., Kochetkova O.D., Kindarova L.B., Kuzmichev L.N., Janus J.D., et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2007, 9:432-449.
47. 2+ transients in mouse embryos during the first mitotic division. J Cell Biol 1996, 132:915-923.
48. de Grouchy J. Human parthenogenesis: a fascinating single event. Biomedicine 1980, 32:51-53.
49. Kanatsu-Shinohara M., Inoue K., Lee J., Yoshimoto M., Ogonuki N., Miki H., et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 2004, 119:1001-1012.
50. Guan K., Wagner S., Unsold B., Maier L.S., Kaiser D., Hemmerlein B., et al. Generation of functional cardiomyocytes from adult mouse spermatogonial stem cells. Circ Res 2007, 100:1615-1625.
51. Conrad S., Renninger M., Hennenlotter J., Wiesner T., Just L., Bonin M., et al. Generation of pluripotent stem cells from adult human testis. Nature 2008, 456:344-349.
52. Ko K., Arauzo-Bravo M.J., Tapia N., Kim J., Lin Q., Bernemann C., et al., Human adult germline stem cells in question. Nature 2010;465: E1; discussion E3.
53. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
54. Briggs R., King T.J. Transplantation of living nuclei from blastula cells into enucleated frogs' eggs. Proc Natl Acad Sci USA 1952, 38:455-463.
55. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., Campbell K.H. Viable offspring derived from fetal and adult mammalian cells. Nature 1997, 385:810-813.
56. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
57. Yamanaka S., Blau H.M. Nuclear reprogramming to a pluripotent state by three approaches. Nature 2010;465: 704-712.
58. Kim K., Doi A., Wen B., Ng K., Zhao R., Cahan P., et al., Epigenetic memory in induced pluripotent stem cells. Nature 2010;467: 285-290.
59. Polo J.M., Liu S., Figueroa M.E., Kulalert W., Eminli S., Tan K.Y., et al., Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010;28: 848-855.
60. Zwi L., Caspi O., Arbel G., Huber I., Gepstein A., Park I.H., et al. Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009, 120:1513-1523.
61. Cibelli J.B., Grant K.A., Chapman K.B., Cunniff K., Worst T., Green H.L., et al. Parthenogenetic stem cells in nonhuman primates. Science 2002, 295:819.
62. Naito H., Melnychenko I., Didie M., Schneiderbanger K., Schubert P., Rosenkranz S., et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 2006, 114:I72-I78.
63. Zimmermann W.H., Schneiderbanger K., Schubert P., Didie M., Munzel F., Heubach J.F., et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 2002, 90:223-230.
64. Kattman S.J., Adler E.D., Keller G.M. Specification of multipotential cardiovascular progenitor cells during embryonic stem cell differentiation and embryonic development. Trends Cardiovasc Med 2007, 17:240-246.
65. Rohwedel J., Guan K., Zuschratter W., Jin S., Ahnert-Hilger G., Furst D., et al. Loss of beta1 integrin function results in a retardation of myogenic, but an acceleration of neuronal, differentiation of embryonic stem cells in vitro. Dev Biol 1998, 201:167-184.
66. Ross R.S., Borg T.K. Integrins and the myocardium. Circ Res 2001, 88:1112-1119.
67. Forbes M.S., Sperelakis N. Intercalated discs of mammalian heart: a review of structure and function. Tissue Cell 1985, 17:605-648.
68. Unger C., Skottman H., Blomberg P., Dilber M.S., Hovatta O. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 2008, 17:R48-R53.
69. Gepstein L. Derivation and potential applications of human embryonic stem cells. Circ Res 2002, 91:866-876.
70. Zandstra P.W., Bauwens C., Yin T., Liu Q., Schiller H., Zweigerdt R., et al. Scalable production of embryonic stem cell-derived cardiomyocytes. Tissue Eng 2003, 9:767-778.
71. Hentze H., Soong P.L., Wang S.T., Phillips B.W., Putti T.C., Dunn N.R. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2009.
72. Narva E., Autio R., Rahkonen N., Kong L., Harrison N., Kitsberg D., et al., High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol 2010;28: 371-377.
73. Stephenson E., Ogilvie C.M., Patel H., Cornwell G., Jacquet L., Kadeva N., et al., Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. J R Soc Interface. 2010;7 Suppl 6:S677-88.
74. Thomson A., Wojtacha D., Hewitt Z., Priddle H., Sottile V., Di Domenico A., et al. Human embryonic stem cells passaged using enzymatic methods retain a normal karyotype and express CD30. Cloning Stem Cells 2008, 10:89-106.
75. Taylor C.J., Bolton E.M., Pocock S., Sharples L.D., Pedersen R.A., Bradley J.A. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 2005, 366:2019-2025.
76. Nakajima F., Tokunaga K., Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells 2007, 25:983-985.
77. Revazova E.S., Turovets N.A., Kochetkova O.D., Agapova L.S., Sebastian J.L., Pryzhkova M.V., et al. HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 2008, 10:11-24.
78. Kel A., Voss N., Valeev T., Stegmaier P., Kel-Margoulis O., Wingender E. ExPlain: finding upstream drug targets in disease gene regulatory networks. SAR QSAR Environ Res 2008, 19:481-494.
79. Eschenhagen T., Zimmermann W.H. Engineering myocardial tissue. Circ Res 2005, 97:1220-1231.
80. Hansen A., Eder A., Bonstrup M., Flato M., Mewe M., Schaaf S., et al., Development of a drug screening platform based on engineered heart tissue. Circ Res 2010;107: 35-44.
81. Zimmermann W.H., Melnychenko I., Wasmeier G., Didie M., Naito H., Nixdorff U., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006, 12:452-458.
82. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12:459-465.
83. Chachques J.C., Trainini J.C., Lago N., Masoli O.H., Barisani J.L., Cortes-Morichetti M., et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): one year follow-up. Cell Transplant 2007, 16:927-934.
84. Bel A., Planat-Bernard V., Saito A., Bonnevie L., Bellamy V., Sabbah L., et al., Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010;122: S118-S123.
85. Kasahara H., Bartunkova S., Schinke M., Tanaka M., Izumo S. Cardiac and extracardiac expression of Csx/Nkx2.5 homeodomain protein. Circ Res 1998, 82:936-946.
86. Pfaff S.L., Mendelsohn M., Stewart C.L., Edlund T., Jessell T.M. Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 1996, 84:309-320.
87. Arceci R.J., King A.A., Simon M.C., Orkin S.H., Wilson D.B. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol 1993, 13:2235-2246.
88. Barnes R.M., Firulli B.A., Conway S.J., Vincentz J.W., Firulli A.B. Analysis of the Hand1 cell lineage reveals novel contributions to cardiovascular, neural crest, extra-embryonic, and lateral mesoderm derivatives. Dev Dyn. 2010;239:3086-97.